Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed Monday it was somewhat effective at saving lives if given early in the illness, but not later. The antiviral treatment is being developed by the Japanese company Toyama Chemical, and has been shown safe and…
Source: Limited promise in early results from Ebola drug trial
Tuesday, February 24, 2015
Limited promise in early results from Ebola drug trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment